TXMD · TherapeuticsMD, Inc. · Executive Compensation
$1.79
-0.04 (-1.92%)
At close · Nov 5
View the 10-Q filed Aug 11, 2026
Return incl. dividend (before tax)
Q2 2022 earnings call transcript
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The potential impact of these factors in conjunction with the uncertainty of the capital markets raises substantial doubt about our ability to continue as a going concern for the next twelve months from the issuance of these financial statements.”View the 10-Q filed Aug 11, 2026
Customer concentration
— top 3 customers 100% of revenue
3 customers — 100% of revenue (the three and six months ended June 30, 2026)
“For the three and six months ended June 30, 2026, 100% of license revenue related to Mayne Pharma, Theramex and Knight.”
Market Cap
$21.07M
Shares
11.57M
Volume · Nov 5
2911
Avg daily vol (3M)
23.41K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Marlan D. Walker | Chief Executive Officer | $759,174 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Michael Donegan | Former Interim Chief Financial Officer | $1,286,663 |
| Marlan D. Walker | Chief Executive Officer | $1,019,817 |
| Joseph Ziegler | Principal Financial and Accounting Officer | $82,900 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Brian Bernick | Former Interim Co-Chief Executive Officer | $1,624,016 |
| Marlan D. Walker | Chief Executive Officer | $1,573,380 |
| Michael Donegan | Former Interim Chief Financial Officer | $914,240 |
| James C. D'Arecca | Former Chief Financial Officer | $207,890 |
| James D’Arecca | Former Chief Financial Officer | $207,890 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| James C. D'Arecca | Former Chief Financial Officer | $1,721,654 |
| James D’Arecca | Former Chief Financial Officer | $1,721,654 |
| Marlan D. Walker | Chief Executive Officer | $1,597,193 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Edward Borkowski | Executive Vice President, Operations | $4,477,154 |
| Robert Finizio | Chief Executive Officer | $2,746,536 |
| Robert G. Finizio | Chief Executive Officer | $2,746,536 |
| John C.K. Milligan | President and Secretary | $2,275,390 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| John C.K. Milligan | President and Secretary | $1,440,639 |
| Robert Finizio | Chief Executive Officer | $1,222,220 |
| Robert G. Finizio | Chief Executive Officer | $1,222,220 |
| Mitchell Krassan | Chief Strategy & Performance Officer | $1,044,994 |
| Daniel A. Cartwright | Chief Financial Officer and Treasurer | $1,014,578 |
| Michael Donegan | Vice President - Finance | $572,084 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Robert Finizio | Chief Executive Officer | $2,724,577 |
| Robert G. Finizio | Chief Executive Officer | $2,724,577 |
| John C.K. Milligan | President and Secretary | $1,701,434 |
| Daniel A. Cartwright | Chief Financial Officer and Treasurer | $1,245,477 |
| Mitchell Krassan | Chief Strategy & Performance Officer | $1,129,352 |
| Michael Donegan | Vice President - Finance | $703,480 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Robert G. Finizio | Chief Executive Officer | $2,983,955 |
| Robert Finizio | Chief Executive Officer | $2,983,955 |
| John C.K. Milligan | President and Secretary | $1,840,029 |
| Daniel A. Cartwright | Chief Financial Officer and Treasurer | $1,352,785 |
| Mitchell Krassan | Chief Strategy & Performance Officer | $1,221,410 |
| Michael Donegan | Vice President - Finance | $531,491 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Joseph Ziegler | Principal Financial and Accounting Officer | Appointed | 2023-08-18 |
| Michael C. Donegan | Principal Financial and Accounting Officer | Resigned | 2023-08-18 |
| Michael Donegan | Interim Chief Financial Officer, Chief Accounting Officer and Vice President Finance | Terminated | 2023-01-18 |
| Angus C. Russell | board of directors | Resigned | 2023-01-03 |
| Marlan Walker | Principal Executive Officer | Appointed | 2023-01-03 |
| Karen L. Ling | board of directors | Resigned | 2023-01-03 |
| Jules A. Musing | board of directors | Resigned | 2023-01-03 |
| Paul M. Bisaro | board of directors | Resigned | 2023-01-03 |
| Tommy Thompson | Executive Chairman of the Board | Appointed | 2022-09-12 |
| Hugh O'Dowd | Chief Executive Officer | Terminated | 2022-09-12 |
| Mark Glickman | Interim Co-Chief Executive Officer | Appointed | 2022-09-12 |
| Brian Bernick | Interim Co-Chief Executive Officer | Appointed | 2022-09-12 |
| Justin Roberts | director | Appointed | 2022-08-29 |
Leadership
- Brian Bernick CEO
- Mark Glickman CEO
- Marlan D. Walker CEO, General Counsel
- Robert Finizio CEO, Board Member
- Tommy G. Thompson Chairman, Board Member
- Tommy Thompson Chairman
- James C. D'Arecca CFO
- Joseph Ziegler CFO
- Adam Miller CIO
- Cooper C. Collins Board Member
- Gail K. Naughton Board Member
- Gail K. Naughton, Ph.D. Board Member
- Gail Naughton Board Member
- Hugh O'Dowd Board Member
- J. Martin Carroll Board Member
- Justin Roberts Board Member
- Paul Bisaro Board Member
- Robert G. Finizio Board Member